1-9 of 9
Ewa Medras
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Giuseppe Saglio, MD, Richard A. Larson, MD, Hagop M. Kantarjian, MD, Dong-Wook Kim, Surapol Issaragrisil, MD, Philipp Le Coutre, MD, Gabriel Etienne, MD PhD, Carla Boquimpani, MD, Richard E. Clark, MA, MD MRCP, FRCPath, Viviane Dubruille, MD, Ian W. Flinn, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Ewa Medras, MD, Maria Zanichelli, MD, Israel Bendit, MD PhD, Manu Sondhi, MD PhD, Ksenia Titorenko, MS, Claire Nourry-Boulot, PhD, Paola Aimone, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2924.
https://doi.org/10.1182/blood-2019-128761
Published: 2019
Journal Articles

Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora Tybor, Tomasz Sacha, Joanna Waclaw, Joanna Niesiobedzka-Krezel, Olga Grzybowska-Izydorczyk, Ewa Medras, Izabela Deren-Wagemann, Elzbieta Patkowska, Ilona Seferynska, Krzysztof Lewandowski, Anna Wache, Beata Blajer-Olszewska, Marzena Watek, Ewa Wasilewska, Tomasz Stoklosa, Krzysztof Warzocha, Krzysztof Jamroziak
Journal: Blood
Blood (2017) 130 (Supplement 1): 2887.
https://doi.org/10.1182/blood.V130.Suppl_1.2887.2887
Published: 2017
Journal Articles

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora-Tybor, Tomasz Sacha, Joanna Waclaw, Joanna Niesiobedzka, Olga Grzybowska-Izydorczyk, Ewa Medras, Izabela Deren-Wagemann, Elzbieta Patkowska, Ilona Seferynska, Krzysztof Lewandowski, Anna Wache, Beata Blajer-Olszewska, Marzena Watek, Krzysztof Warzocha, Krzysztof Jamroziak
Journal: Blood
Blood (2016) 128 (22): 1909.
https://doi.org/10.1182/blood.V128.22.1909.1909
Published: 2016
Journal Articles

Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry

Tomasz Sacha, Joanna Gora-Tybor, Monika Szarejko, MD PhD, Grażyna Bober, MD, Olga Grzybowska-Izydorczyk, Joanna Niesiobędzka-Krężel, MD, Marek Dudziński, MD, Ewa Wasilewska, MD PhD, Krzysztof Myśliwiec, MD, Justyna Gil, MD PhD, Michał Gniot, MD PhD, Iwona Pietkun, MD, Ewa Mędraś, MD PhD, Joanna Wącław, MD, Krzysztof Giannopoulos
Journal: Blood
Blood (2016) 128 (22): 629.
https://doi.org/10.1182/blood.V128.22.629.629
Published: 2016
Journal Articles

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD PhD, Bozena Jazwiec, MSC, Tomasz Wrobel, MDPhD, Kazimierz Kuliczkowski, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 3152.
https://doi.org/10.1182/blood.V124.21.3152.3152
Published: 2014
Journal Articles

CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD, PhD, Prof., Bozena Jazwiec, MSC, Joanna Urbaniak, PhD, Mieczyslaw Wozniak, PhD Prof., Kazimierz Kuliczkowski, Professor
Journal: Blood
Blood (2013) 122 (21): 3990.
https://doi.org/10.1182/blood.V122.21.3990.3990
Published: 2013
Journal Articles

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Joanna Gora-Tybor, MD, PhD, Ewa Medras, MD, PhD, Malgorzata Calbecka, MD, PhD, Agnieszka Kolkowska, MD, Edyta Ponikowska-Szyba, MD, Tadeusz Robak, MD, PhD, Krzysztof Jamroziak, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1491.
https://doi.org/10.1182/blood.V122.21.1491.1491
Published: 2013
Journal Articles

Imatinib in Chronic Myeloid Leukemia - Five Years Single Center Experience.

Jaroslaw Dybko, MD, Ewa Medras, MD, Renata Bednarz, MSci, Donata Urbaniak, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2007) 110 (11): 4558.
https://doi.org/10.1182/blood.V110.11.4558.4558
Published: 2007